维普期刊资源整合服务平台（V6.5）

94篇 您的检索式：作者名="Oxnard"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib显示文摘	Oxnard GR Janjigian YY Arcila ME		0，，19：	1
2	The combination of locomotor features of the primate sholder girdle by canonical analysis显示文摘	Ashton EH Healy MJR Oxnard CE	1965	J Zool1965，147，：	1
3	Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘	Arcila ME Oxnard GR Nafa K		0，，05：	1
4	Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer:Distinct natural history of patients with tumors harboring the T790M mutation显示文摘	Oxnard GR Arcila ME Sima CS		0，，06：	1
5	ALCHEMIST:Bringing genomic discovery and targeted therapies to early-stage lung cancer显示文摘	Gerber DE Oxnard GR Govindan R	2015	Clin Pharmacol Ther2015，97，5：	1
6	Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to Erlotinib or Gefitinib:Implications for clinical trial design显示文摘	Chaft JE Oxnard GR Sima CS		0，，19：	1
7	Extinction of snub-nosed monkeys in China during the past 400 years 显示文摘	Li BG Pan RL Oxnard CE	2002	Interna- tional Journal Primatology2002，23，：	1
8	Delay of chemotherapy through use of post-progression Erlotinib in patients with EGFR-mutant lung cancer显示文摘	Oxnard GR Lo P Jackman DM		0，，15：	1
9	Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib:implications for clinical trial design显示文摘	Chaft JE Oxnard GR Sima CS		0，，19：	1
10	Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA显示文摘	Oxnard G R Paweletz C P Kuang Y	2014	Clin Cancer Res2014，20，6：	1
11	Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non‐small cell lung cancer显示文摘	Adrian G. Sacher Pasi A. J?nne Geoffrey R. Oxnard	2014	Cancer2014，，15：	1
12	Maintained sensi-tivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lungcancer recurring after adjuvant erlotinib or gefitinib 显示文摘	Oxnard GR Janjigian YY Arcila ME	2011	ClinCancer Res2011，17，19：	1
13	New strategies in over- coming acquired resistance to epidermal growth factor receptor tyro- sine kinase inhibitors in lung cancer显示文摘	Oxnard GR Arcila ME Chmielecki J	2011	Clin CancerRes2011，17，17：	1
14	Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘	Arcila ME Oxnard GR Nafa K	2011	Clin Cancer Res2011，17，5：	1
15	New targetable oncogenes in non- small-cell lung cancer显示文摘	Oxnard GR Binder A Jinne PA	2013	J Clin Oncol2013，31，8：	1
16	Some haematological changes during pregnancy in the rhesus monkey (Macaco mulatta)显示文摘	Spicer EJ Oxnard CE	1967	Folia Primatol (Basel)1967，6，3：	1
17	Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design显示文摘	Chaft jE Oxnard GR Sima CS	2011	Clin Cancer Res2011，17，19：	1
18	Maintained Sensitivity to EGFR tyrosine Kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib显示文摘	Oxnard GR Janjigian YY Arcila ME	2011	Clin Cancer Res2011，17，19：	1
19	'Pulsatile' high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer显示文摘	Grommes C Oxnard GR Kris MG	2011	Neuro Oncol2011，13，12：	1
20	“Pulsatile” high-doseweekly erlotinib for CNS metastases from EGFR mutant non-smallcell lung cancer显示文摘	Grommes C Oxnard GR Kris MG	2011	Neuro Oncol2011，13，12：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示